Cargando…

Metabolic systems analysis identifies a novel mechanism contributing to shock in patients with endotheliopathy of trauma (EoT) involving thromboxane A2 and LTC(4)

PURPOSE: Endotheliopathy of trauma (EoT), as defined by circulating levels of syndecan-1 ≥ 40 ng/mL, has been reported to be associated with significantly increased transfusion requirements and a doubled 30-day mortality. Increased shedding of the glycocalyx points toward the endothelial cell membra...

Descripción completa

Detalles Bibliográficos
Autores principales: Henriksen, Hanne H., Marín de Mas, Igor, Herand, Helena, Krocker, Joseph, Wade, Charles E., Johansson, Pär I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260291/
https://www.ncbi.nlm.nih.gov/pubmed/35813244
http://dx.doi.org/10.1016/j.mbplus.2022.100115
_version_ 1784741992669904896
author Henriksen, Hanne H.
Marín de Mas, Igor
Herand, Helena
Krocker, Joseph
Wade, Charles E.
Johansson, Pär I.
author_facet Henriksen, Hanne H.
Marín de Mas, Igor
Herand, Helena
Krocker, Joseph
Wade, Charles E.
Johansson, Pär I.
author_sort Henriksen, Hanne H.
collection PubMed
description PURPOSE: Endotheliopathy of trauma (EoT), as defined by circulating levels of syndecan-1 ≥ 40 ng/mL, has been reported to be associated with significantly increased transfusion requirements and a doubled 30-day mortality. Increased shedding of the glycocalyx points toward the endothelial cell membrane composition as important for the clinical outcome being the rationale for this study. RESULTS: The plasma metabolome of 95 severely injured trauma patients was investigated by mass spectrometry, and patients with EoT vs. non-EoT were compared by partial least square-discriminant analysis, identifying succinic acid as the top metabolite to differentiate EoT and non-EoT patients (VIP score = 3). EoT and non-EoT patients’ metabolic flux profile was inferred by integrating the corresponding plasma metabolome data into a genome-scale metabolic network reconstruction analysis and performing a functional study of the metabolic capabilities of each group. Model predictions showed a decrease in cholesterol metabolism secondary to impaired mevalonate synthesis in EoT compared to non-EoT patients. Intracellular task analysis indicated decreased synthesis of thromboxanA2 and leukotrienes, as well as a lower carnitine palmitoyltransferase I activity in EoT compared to non-EoT patients. Sensitivity analysis also showed a significantly high dependence of eicosanoid-associated metabolic tasks on alpha-linolenic acid as unique to EoT patients. CONCLUSIONS: Model-driven analysis of the endothelial cells’ metabolism identified potential novel targets as impaired thromboxane A2 and leukotriene synthesis in EoT patients when compared to non-EoT patients. Reduced thromboxane A2 and leukotriene availability in the microvasculature impairs vasoconstriction ability and may thus contribute to shock in EoT patients. These findings are supported by extensive scientific literature; however, further investigations are required on these findings.
format Online
Article
Text
id pubmed-9260291
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92602912022-07-08 Metabolic systems analysis identifies a novel mechanism contributing to shock in patients with endotheliopathy of trauma (EoT) involving thromboxane A2 and LTC(4) Henriksen, Hanne H. Marín de Mas, Igor Herand, Helena Krocker, Joseph Wade, Charles E. Johansson, Pär I. Matrix Biol Plus Articles from the Special Issue on The Glycocalyx: Pathobiology and Repair; Edited by Jillian Richter & Ralph Sanderson PURPOSE: Endotheliopathy of trauma (EoT), as defined by circulating levels of syndecan-1 ≥ 40 ng/mL, has been reported to be associated with significantly increased transfusion requirements and a doubled 30-day mortality. Increased shedding of the glycocalyx points toward the endothelial cell membrane composition as important for the clinical outcome being the rationale for this study. RESULTS: The plasma metabolome of 95 severely injured trauma patients was investigated by mass spectrometry, and patients with EoT vs. non-EoT were compared by partial least square-discriminant analysis, identifying succinic acid as the top metabolite to differentiate EoT and non-EoT patients (VIP score = 3). EoT and non-EoT patients’ metabolic flux profile was inferred by integrating the corresponding plasma metabolome data into a genome-scale metabolic network reconstruction analysis and performing a functional study of the metabolic capabilities of each group. Model predictions showed a decrease in cholesterol metabolism secondary to impaired mevalonate synthesis in EoT compared to non-EoT patients. Intracellular task analysis indicated decreased synthesis of thromboxanA2 and leukotrienes, as well as a lower carnitine palmitoyltransferase I activity in EoT compared to non-EoT patients. Sensitivity analysis also showed a significantly high dependence of eicosanoid-associated metabolic tasks on alpha-linolenic acid as unique to EoT patients. CONCLUSIONS: Model-driven analysis of the endothelial cells’ metabolism identified potential novel targets as impaired thromboxane A2 and leukotriene synthesis in EoT patients when compared to non-EoT patients. Reduced thromboxane A2 and leukotriene availability in the microvasculature impairs vasoconstriction ability and may thus contribute to shock in EoT patients. These findings are supported by extensive scientific literature; however, further investigations are required on these findings. Elsevier 2022-06-18 /pmc/articles/PMC9260291/ /pubmed/35813244 http://dx.doi.org/10.1016/j.mbplus.2022.100115 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles from the Special Issue on The Glycocalyx: Pathobiology and Repair; Edited by Jillian Richter & Ralph Sanderson
Henriksen, Hanne H.
Marín de Mas, Igor
Herand, Helena
Krocker, Joseph
Wade, Charles E.
Johansson, Pär I.
Metabolic systems analysis identifies a novel mechanism contributing to shock in patients with endotheliopathy of trauma (EoT) involving thromboxane A2 and LTC(4)
title Metabolic systems analysis identifies a novel mechanism contributing to shock in patients with endotheliopathy of trauma (EoT) involving thromboxane A2 and LTC(4)
title_full Metabolic systems analysis identifies a novel mechanism contributing to shock in patients with endotheliopathy of trauma (EoT) involving thromboxane A2 and LTC(4)
title_fullStr Metabolic systems analysis identifies a novel mechanism contributing to shock in patients with endotheliopathy of trauma (EoT) involving thromboxane A2 and LTC(4)
title_full_unstemmed Metabolic systems analysis identifies a novel mechanism contributing to shock in patients with endotheliopathy of trauma (EoT) involving thromboxane A2 and LTC(4)
title_short Metabolic systems analysis identifies a novel mechanism contributing to shock in patients with endotheliopathy of trauma (EoT) involving thromboxane A2 and LTC(4)
title_sort metabolic systems analysis identifies a novel mechanism contributing to shock in patients with endotheliopathy of trauma (eot) involving thromboxane a2 and ltc(4)
topic Articles from the Special Issue on The Glycocalyx: Pathobiology and Repair; Edited by Jillian Richter & Ralph Sanderson
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260291/
https://www.ncbi.nlm.nih.gov/pubmed/35813244
http://dx.doi.org/10.1016/j.mbplus.2022.100115
work_keys_str_mv AT henriksenhanneh metabolicsystemsanalysisidentifiesanovelmechanismcontributingtoshockinpatientswithendotheliopathyoftraumaeotinvolvingthromboxanea2andltc4
AT marindemasigor metabolicsystemsanalysisidentifiesanovelmechanismcontributingtoshockinpatientswithendotheliopathyoftraumaeotinvolvingthromboxanea2andltc4
AT herandhelena metabolicsystemsanalysisidentifiesanovelmechanismcontributingtoshockinpatientswithendotheliopathyoftraumaeotinvolvingthromboxanea2andltc4
AT krockerjoseph metabolicsystemsanalysisidentifiesanovelmechanismcontributingtoshockinpatientswithendotheliopathyoftraumaeotinvolvingthromboxanea2andltc4
AT wadecharlese metabolicsystemsanalysisidentifiesanovelmechanismcontributingtoshockinpatientswithendotheliopathyoftraumaeotinvolvingthromboxanea2andltc4
AT johanssonpari metabolicsystemsanalysisidentifiesanovelmechanismcontributingtoshockinpatientswithendotheliopathyoftraumaeotinvolvingthromboxanea2andltc4